Adjuvanted A Influenza Vaccine
H1N1 Influenza Virus
Chiltern Pesquisa Clinica LtdavaccinePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the H1N1 Influenza Virus cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
as03-adjuvanted h1n1 pandemic influenza vaccine University Health Network, Toronto | Phase 3 | BB |
non-adjuvanted A(H1N1) influenza vaccine Chiltern Pesquisa Clinica Ltda | Phase 3 | BB |
Same molecule, other indications
Adjuvanted A Influenza Vaccine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →